Over-Medication of Psychotropic Drugs & African-American Girls in Foster Care. Submission to the United Nations Working Group on the Issue of Discrimination Against Women in Law and in Policy.
The Franklin Law Group, P.C.
Permission to Copy
Published: November 2015
US Human Rights Network
250 Georgia Ave SE, Suite 330
Atlanta, GA 30312
This report to the United Nations explains that children of African descent in the United States continue to be a vulnerable population marginalized by persistent race, gender, and economic discrimination in violation of their human rights, and that African American girls in foster care are particularly vulnerable to the overmedication of psychotropic drugs. Background information is provided onteh seid effects and long-term consequences of psychotropic drugs, the use of psychotropic medications with foster children, and the high rates of African-American children taking psychotropic mediations. The violations of the human rights of these children under the ICERD treaty are explained and the following recommendations are made: require health and human services, State, and local governments to collect data concerning psychotropic medication use and prescription categorized by race and ethnic origin that is disaggregated by age and gender-identity for foster care children, enact federal, State and local legislation extending the oversight and monitoring of the use of psychotropic medications by foster care children beyond social service agencies to include, but not limited to, courts, school systems, and juvenile service systems; and encourage health and human services, State, and local governments to provide culturally-competent, age appropriate, gender and trauma-informed, psycho-social therapeutic services, require State and local residential treatment centers for children to obtain informed consents from older youth, and ban forced psychotropic drugging. 28 references.
foster children; human rights; United Nations; psychotropic medication; African Americans; female victims; mental health services; drug therapy; antidepressants